• Analysis of signaling cascades from myeloma cells treated with pristimerin 

      Almaghrbi, Heba; Elkardawy, Rehab; Kumar. S, Udhaya; Kuttikrishnan, Shilpa; Abunada, Taghreed; ... more authors ( Elsevier , 2022 , Book chapter)
      Multiple myeloma (MM) is the 2nd most frequently diagnosed blood cancer after non-Hodgkin's lymphoma. The present study aimed to identify the differentially expressed genes (DEGs) between the control and pristimerin-treated ...
    • Association of Vitamin D Genetic Risk Score with Noncommunicable Diseases: A Systematic Review 

      Almaghrbi, Heba; Al-Shafai, Mashael; Al-Asmakh, Maha; Bawadi, Hiba ( MDPI , 2023 , Article)
      Background and Aims: The genetic risk score (GRS) is an important tool for estimating the total genetic contribution or susceptibility to a certain outcome of interest in an individual, taking into account their genetic ...
    • Non-coding RNAs as biomarkers of myocardial infarction 

      Almaghrbi, Heba; Giordo, Roberta; Pintus, Gianfranco; Zayed, Hatem ( Elsevier , 2023 , Article)
      Non-coding RNAs (ncRNAs) encompass a family of ubiquitous RNA molecules that lack protein-coding potential and have tissue-specific expression. A significant body of evidence indicates that ncRNA's aberrant expression plays ...